Phase Id Trial to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Advanced Stage Gastric Carcinoma
Latest Information Update: 24 Feb 2023
At a glance
- Drugs Dalpiciclib (Primary) ; Pyrotinib (Primary)
- Indications Colorectal cancer; Gastric cancer; Solid tumours
- Focus Adverse reactions
- 21 Jan 2023 Results presented at the 2023 Gastrointestinal Cancers Symposium.
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology
- 12 Mar 2019 Planned End Date changed from 1 Aug 2019 to 1 Aug 2020.